Prot# SPD758-216: An Open-Label, Single-Arm, Multi-Center, Phase 2 Study of Troxatyl (troxacitabine) Administered by Continuous Infusion in Patients with Acute Myeloid Leukemia (AML) in Second Salvage

  • Tallman, Martin Stuart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/3/06 → 12/27/11

Funding

  • SGX Pharmaceuticals, Inc. (SPD758-216)